
Use of the drug by itself as a monotherapy is explicitly discouraged by the World Health Organization as there have been signs that malarial parasites are developing resistance to the drug. Combination therapies that include artemisinin are the preferred treatment for malaria and are both effective and well tolerated in patients. The drug is also increasingly being used in vivax malaria as well as being a topic of research in cancer treatment.




We are keep looking for the new partners which we can setup the long-term relationship to provide the reliable supply and competitive pricing that all markets demand. For more information about Artemisinin, please feel free to contact our Commercial Director at: minhut@catkhanh.com or via mobile: +84 91 766 2468